Usana Health Sciences (USNA) Asset Writedowns and Impairment (2023 - 2026)
Usana Health Sciences has reported Asset Writedowns and Impairment over the past 5 years, most recently at $1.3 million for Q2 2026.
- Quarterly Asset Writedowns and Impairment rose 7.27% to $1.3 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Apr 2026, up 898.92% year-over-year, with the annual reading at $2.7 million for FY2026, N/A changed from the prior year.
- Asset Writedowns and Impairment was $1.3 million for Q2 2026 at Usana Health Sciences, up from $264000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $2.3 million in Q2 2023 and troughed at -$1.9 million in Q4 2024.
- The 4-year median for Asset Writedowns and Impairment is $423000.0 (2023), against an average of $506076.9.
- Year-over-year, Asset Writedowns and Impairment tumbled 273.32% in 2024 and then skyrocketed 113.98% in 2026.
- A 4-year view of Asset Writedowns and Impairment shows it stood at -$506000.0 in 2023, then tumbled by 273.32% to -$1.9 million in 2024, then soared by 119.59% to $370000.0 in 2025, then skyrocketed by 251.08% to $1.3 million in 2026.
- Per Business Quant, the three most recent readings for USNA's Asset Writedowns and Impairment are $1.3 million (Q2 2026), $264000.0 (Q1 2026), and $370000.0 (Q3 2025).